Nadav Kidron

Mr. Kidron serves as Chief Executive Officer & Director of Oramed Pharmaceuticals, a company originating from the Hadassah Medical Center in Jerusalem, which he co-founded in 2006. At Oramed, Nadav raised about $100M for the company. He also executed the largest licensing deal between a Chinese company and an Israeli biotechnology company totaling US$650M of anticipated investment in the project from the Chinese partner.

Nadav is an Entrepreneur whose experience includes senior executive roles in a wide range of industries. He co-founded Artemis Therapeutics together with a leading life sciences bank from NY and the company is based on a technology that originates from Hadassah Medical Center and the Hebrew University of Jerusalem. Nadav co-founded Entera Bio as a joint venture formed by Oramed and DNA Biomedical Solutions. He is a member of the IATI Board, an international lecturer in Israel’s entrepreneurial culture as well as a speaker on the country’s roots as an oasis of innovative ideas.

Nadav holds a BSc in Law and an International MBA, both from Bar-Ilan University, Israel. He is a Fellow of the Merage Business Executive Leadership Program and a Member of the Israeli Bar Association.